The trademark application FRONTIER MEDICINES was filed by Frontier Medicines Corporation, a U.S. corporation (the "Applicant"). The application was published for oppositions on September 19, 2022, and it was registered by office on December 27, 2022 without any oppositions.
The application was filed in English (German was selected as the second language).
Change of name and professional address of the trademark registration was recorded on August 28, 2024.
Goods And Services
The mark was filed in class 5 with Small molecule pharmaceuticals for the treatment of cancer, heart disease, blood pressure, Alzheimer's disease, arthritis, diabetes, cancer, obesity, mitochondrial disease, autoimmune diseases, hypertension, inflammatory bowel disease, amyotrophic lateral sclerosis, neurological diseases, allergies and asthma, hepatic disease, pulmonary disease, renal disease, and infectious diseases in humans.
The mark was filed in class 42 with following description of goods:
Pharmaceutical research services
Pharmaceutical products development
Research and development of pharmaceuticals for the treatment of cancer.